Inhibition of P-glycoprotein ATPase activity by beryllium fluoride

被引:60
|
作者
Sankaran, B [1 ]
Bhagat, S [1 ]
Senior, AE [1 ]
机构
[1] UNIV ROCHESTER,MED CTR,DEPT BIOCHEM & BIOPHYS,ROCHESTER,NY 14642
关键词
D O I
10.1021/bi970034s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATPase activity of P-glycoprotein (multidrug-resistance protein) was found to be potently inhibited by beryllium fluoride (BeFx) in combination with MgATP, MgADP, or corresponding Mg-8-azido-nucleotides, Inhibition was due to trapping of nucleoside diphosphate at catalytic sites. Full inhibition was achieved on trapping of 1 mol of nucleotide per mol of Pgp. Reactivation was slow (t(1/2) = 32 min at 37 degrees C), and release of trapped nucleotide correlated with recovery of ATPase. Trapping of 8-azido-ADP followed by UV irradiation yielded permanent inactivation and specific labelling of Pgp in plasma membranes. Both N- and C-terminal nucleotide binding sites were labelled. These findings give strong confirmation of the concepts that in intact Pgp both nucleotide sites are active in MgATP hydrolysis, and that they interact strongly. The characteristics of inhibition by BeFx were similar in general to those seen with vanadate. However, PPi gave strong protection against BeFx inhibition, and in this respect, inhibition by BeFx was clearly different from vanadate inhibition.
引用
收藏
页码:6847 / 6853
页数:7
相关论文
共 50 条
  • [41] MOLECULAR DYNAMICS SIMULATIONS OF P-GLYCOPROTEIN AND THE NEED FOR SPECIFIC INHIBITION OF AED BINDING TO P-GLYCOPROTEIN
    Narayanan, Jaishree T.
    Phillips, C.
    EPILEPSIA, 2008, 49 : 351 - 352
  • [42] P-glycoprotein ATPase activity requires lipids to activate a switch at the first transmission interface
    Loo, Tip W.
    Clarke, David M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 472 (02) : 379 - 383
  • [43] A luminescent method for measuring drug-dependent changes in P-glycoprotein ATPase activity
    Cali, JJ
    Ma, DP
    DRUG METABOLISM REVIEWS, 2004, 36 : 56 - 56
  • [44] Interaction of CJX2, an amlodipine derivative with human P-glycoprotein ATPase activity
    Ji, Bian-Sheng
    He, Ling
    DRUG DEVELOPMENT RESEARCH, 2008, 69 (01) : 42 - 47
  • [45] Inhibition of P-glycoprotein ATPase and its transport function of Helicoverpa armigera by morin, quercetin and phloroglucinol
    Aurade, Ravindra M.
    Akbar, S. Md.
    Goud, Hanumanth
    Jayalakshmi, Senigala K.
    Sreeramulu, Kuruba
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2011, 101 (03) : 212 - 219
  • [46] Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity
    Litman, T
    Zeuthen, T
    Skovsgaard, T
    Stein, WD
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (02): : 159 - 168
  • [47] Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements
    Schmid, D
    Ecker, G
    Kopp, S
    Hitzler, M
    Chiba, P
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (09) : 1447 - 1456
  • [48] Expression and activity of P-glycoprotein in the retina
    Sinha, A
    Maines, LW
    Antonetti, DA
    Smith, CD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [49] Increased uptake of quinine into by inhibition of P-glycoprotein
    Pussard, Eric
    Merzouk, Mourad
    Barennes, Hubert
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 32 (02) : 123 - 127
  • [50] Inhibition of P-glycoprotein by two artemisinin derivatives
    Steglich, Babette
    Mahringer, Anne
    Li, Ying
    Posner, Gary H.
    Fricker, Gert
    Efferth, Thomas
    NATURAL PRODUCTS AND BIOPROSPECTING, 2012, 2 (02): : 59 - 64